Letter to the Editor: The Application of Interleukin-1 Antagonists in Patients With Megalencephalic Leukoencephalopathy With Subcortical Cysts: Caution Warranted
Pediatr Neurol. 2024 Jan:150:15-16.
doi: 10.1016/j.pediatrneurol.2023.10.009.
Epub 2023 Oct 21.
1 Department of Child Neurology, Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam University Medical Centers, Location Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.
2 Istanbul Faculty of Medicine, Division of Child Neurology, Department of Neurology, Istanbul University, Istanbul, Turkey.
3 Department of Pediatric Neurology, Center for Neurosciences and Research, NH Hospital, RN Tagore International Institute, Kolkata, India.
4 Unit of Neuromuscular and Neurodegenerative Disorders, IRCCS Bambino Gesù Children's Research Hospital, Rome, Italy.
5 Department of Neurology and Neurosurgery, Pediatric and Human Genetics, McGill University, Montreal, Quebec, Canada; Child Health and Development Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada; Division of Medical Genetics, Department of Specialized Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
6 Department of Neurology and Developmental Medicine, Kennedy Krieger Institute, Baltimore, Maryland.
7 Department of Child Neurology, Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam University Medical Centers, Location Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands; Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands. Electronic address: ms.vanderknaap@amsterdamumc.nl.